biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
15:08 One-time immune cell therapy shrank rare sarcomas in 4 of 8, maker says✦15:05 Low-dose aspirin tied to lower dementia risk in older adults, report says✦15:05 Experimental drug made old rats' liver cells clear waste like young ones✦15:02 UK approves a twice-daily pill for severe autoimmune hair loss✦09:06 Ozempic-style drugs tied to more hair loss in large health-record studies✦05:35 One-time immune cell therapy held MS steady in early trial, maker says✦09:00 Mice that ate 30% less built up fewer DNA mutations, most in the liver✦08:59 Newer lung cancer pill added nearly 6 months of life versus older drugs✦15:08 One-time immune cell therapy shrank rare sarcomas in 4 of 8, maker says✦15:05 Low-dose aspirin tied to lower dementia risk in older adults, report says✦15:05 Experimental drug made old rats' liver cells clear waste like young ones✦15:02 UK approves a twice-daily pill for severe autoimmune hair loss✦09:06 Ozempic-style drugs tied to more hair loss in large health-record studies✦05:35 One-time immune cell therapy held MS steady in early trial, maker says✦09:00 Mice that ate 30% less built up fewer DNA mutations, most in the liver✦08:59 Newer lung cancer pill added nearly 6 months of life versus older drugs
← All story threadsSTORY THREAD

Leqselvi pill for autoimmune hair loss.

1 report so far. New developments are added to this thread as they happen.

  1. Oct 26, 2026
    UK REGULATOR APPROVES IT FOR SEVERE CASESUK approval

    UK approves a twice-daily pill for severe autoimmune hair loss

    Britain's medicines regulator approved Leqselvi, a tablet that calms part of the immune system, for adults with severe alopecia areata. In trials, about 3 in 10 regrew most of their scalp hair in 24 weeks.